Abstract
Hunter syndrome is an X-linked metabolic storage disorder arising from deficiency of iduronate sulfatase enzyme activity. Despite the successful use of hematopoietic cell transplantation for a variety of lysosomal and peroxisomal storage diseases, limited benefit occurs following transplantation in either the severe or mild forms of Hunter syndrome. A brief ethical commentary is provided on the case of a boy with mucopolysaccharidosis IIB (ie the mild form) who received an unrelated umbilical cord blood transplant to improve his future quality of life. Bone Marrow Transplantation (2000) 25, 1097–1099.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lowery RB, Applegarth DA, Toone JR et al. An update on the frequency of mucopolysaccharide syndromes in British Columbia Hum Genet 1990 85: 389–390
Young ID, Harper PS . The natural history of the severe form of Hunter's syndrome: a study based on 52 cases Dev Med Child Neurol 1983 25: 481–489
Schaap T, Bach G . Incidence of mucopolysaccharidoses in Israel: is Hunter disease a ‘Jewish disease’? Hum Genet 1980 56: 221–223
Meikle PJ, Hopwood JJ, Clague AE, Carey WF . Prevalence of lysosomal storage disorders JAMA 1999 281: 249–254
Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill: New York 1995 2465–2494
Lee C, Dineen TE, Brack M et al. The mucopolysaccharidoses: characterization by cranial MR imaging Am J Neuroradiol 1993 14: 1285–1292
Parsons VJ, Hughes DG, Wraith JE . Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidosis type II) Clin Radiol 1996 51: 719–723
Bax MC, Colville GA . Behaviour in mucopolysaccharide disorders Arch Dis Child 1995 73: 77–81
Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone marrow transplantation Lancet 1981 2: 709–712
Peters C, Balthazor M, Shapiro EG et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome Blood 1996 87: 4894–4902
Peters C, Shapiro EG, Anderson J et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children Blood 1998 91: 2601–2608
Krivit W, Pierpont M, Ayaz K et al. Bone marrow transplantation in the Maroteaux–Lamy syndrome (mucopoly-saccharidosis type VI) New Engl J Med 1984 311: 1606–1611
Aubourg P, Blanche S, Jamabaque I et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation New Engl J Med 1990 332: 1860–1866
Krivit W, Shapiro E, Kennedy W et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation New Engl J Med 1990 322: 28–32
Krivit W, Shapiro EG, Peters C et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy New Engl J Med 1998 338: 1119–1126
Mullen CA, Thompson JN, Richard LA, Chan KW . Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia Bone Marrow Transplant 2000 25: 1093–1097
McKinnis EJ, Sulzbacher S, Rutledge JC et al. Bone marrow transplantation in Hunter syndrome J Pediatr 1996 129: 145–148
Coppa GV, Gabrielli O, Zampini L et al. Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature Pediatria Medica Chirurgica 1995 17: 227–235
Bergstrom SK, Quinn JJ, Greenstein R, Ascensao J . Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review Bone Marrow Transplant 1994 14: 653–658
Imaizumi M, Gushi K, Kurobane I et al. Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases Acta Paediatrica Japonica 1994 36: 30–36
Braun SE, Pan D, Aronovich EL et al. Preclinical studies of lymphocyte gene therapy for mild Hunter (mucopoly-saccharidosis type II) Hum Gene Ther 1996 7: 283–290
Whitley CB, McIvor RS, Aronovich EL et al. Retroviral-mediated transfer of the iduronate-2-sulfatase gene intolymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II) Hum Gene Ther 1996 7: 537–549
Weir RF, Peters C . Affirming the decisions adolescents make about life and death Hastings Center Report 1997 27: 29–40
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peters, C., Krivit, W. Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome); an ethical commentary. Bone Marrow Transplant 25, 1097–1099 (2000). https://doi.org/10.1038/sj.bmt.1702398
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702398
Keywords
This article is cited by
-
Recent trends in mucopolysaccharidosis research
Journal of Human Genetics (2019)
-
Characterization of a Novel Mucopolysaccharidosis Type II Mouse Model and Recombinant AAV2/8 Vector-Mediated Gene Therapy
Molecules and Cells (2010)
-
Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications
Journal of Molecular Medicine (2008)
-
Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases
Springer Seminars in Immunopathology (2004)
-
Ethical considerations in allogeneic hematopoietic cell transplantation for children with slowly fatal conditions
Bone Marrow Transplantation (2000)